x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

PharmaSource Podcast

Life Science Networks

Welcome to the PharmaSource podcast: the pharma and biotech podcast that explores the latest trends, challenges, and commercial opportunities shaping the biopharma manufacturing and outsourcing. In each episode we"ll be speaking with top executives, researchers, and outsourcing experts, who share their perspectives on topics such as building a smarter, more sustainable supply chain, how to partner with CDMOs, digital transformation, procurement and external manufacturing strategies, and plenty more

science life sciences

All Episodes

00:19:24

German Biotech Days: Trump’s Biotech Dismantling...

PharmaSource Podcast ·

2025/04/11

“What we’re witnessing is the rapid dismantling of the US research infrastructure… It’s also an opportunity for us here in Europe to step up” Dr. Oliver Schacht, Managing Director of Life Science NordDr. Oliver Schacht, Managing Director of Life Science Nord and Chairman of the Board for BIO Deutschland, spoke at German Biotechnology Days 2025 (DBT) in Heidelberg about the challenges and opportunities this disruption presents for Germany and the European biotech ecosystem.In an interview for the

en

00:14:07

From Family Business to Global CDMO: Bluejet...

PharmaSource Podcast ·

2025/04/08

In the latest episode, we speak to Payal Gandhi, Management Executive – Business Growth at Blue Jet Healthcare explains how the company transformation from a family-owned business to a publicly listed global CDMO since its IPO in 2023.Today, Blue Jet Healthcare has positioned itself as a strategic partner in the pharmaceutical and healthcare arena, emphasizing their customer-first approach and technological capabilities that help bring innovations to life.Read the article here

en

00:28:20

Novartis Gene Therapy: 5 Essential Strategies from...

PharmaSource Podcast ·

2025/04/04

“Europe has roughly double the population of the United States but lower pricing, so it’s a balancing act between how much volume can you get and how little price discount you give.” – Joshi VenugopalJoshi Venugopal, Head of Region Europe for Novartis Gene Therapy & Rare Diseases and Senior Vice President, brings extensive experience spanning R&D, early pipeline development, and in-market commercialisation.Ahead of his keynote at CDMO Live, Joshi shares valuable insights on how to

en

00:33:28

How Fisiopharma Delivers Excellence as an Injectable...

PharmaSource Podcast ·

2025/04/01

“Being unique or special in something is crucial, a key factor in order to gain success in this field.” – Angela MolaschiAngela Molaschi, Chief Commercial Officer at Fisiopharma, and Nicola Cadei, General Manager, bring decades of pharmaceutical industry experience to their leadership roles at this Italian injectable product specialist. Together, they’re expanding the company’s global presence while maintaining its reputation for quality and flexibility.In the latest PharmaSource podcast episode

en

00:38:56

Pharma Digital Transformation - Interview with Dr....

PharmaSource Podcast ·

2025/03/29

"Digital transformation is not about technology deployment. It's about a new way of doing business that allows you to make jumps which were not possible before, like reducing launch time from 70 weeks to 7 weeks." - Dr. Franziskus KathDr. Franziskus Kath, former J&J executive and now independent consultant, brings over 26 years of healthcare industry experience spanning API manufacturing, pharmaceuticals, consumer health, and digital transformation. He most recently orchestrated

en

00:31:12

Bold capacity investments lag despite urgent need for...

PharmaSource Podcast ·

2025/03/24

“What we’re witnessing is a fundamental shift from globalized to decentralized pharma supply chains, yet many companies are hesitant to make the bold capacity investments needed despite recognizing the risks.” – Stephan Fath, Director at Roland BergerStephan Fath is a Director at Roland Berger where he specialises in advising global pharmaceutical, MedTech, and chemical industries. With a dual degree in Business Administration and Chemistry from the University of Dusseldorf, Stephan brings a

en

00:30:24

CDMO Cultural Alignment: Why the Disney effect is...

PharmaSource Podcast ·

2025/03/21

“Every CDMO is going to give you the Disney effect. I want to see what’s below the street. How is that organisation humming below the surface?” says John Philips, highlighting why superficial evaluations are undermining pharmaceutical outsourcing success.John Philips, President at Innopath Consulting, brings over three decades of experience in CDMO partnerships, including leadership roles at Pii (Pharmaceutics International, Inc.), BioDuro-Sundia, Mikart, and Patheon. His focus on bridging the gap

en

00:23:53

Recipharm’s CDMO Evolution: Technology Investment...

PharmaSource Podcast ·

2025/03/19

“Every minute, over 1000 patients are using a product manufactured in one of our sites,” reveals Kerstin Vieluf, Head of Sales at Recipharm.Headquartered in Stockholm, Sweden, Recipharm has over 5,900 employees across 17 sites in Europe, US, India, and Israel and serves more than 400 customers globally.In this exclusive interview ahead of CDMO Live, the leadership team outlines how Recipharm is evolving its capabilities, with significant investments in digital prediction tools, expanded development

en

00:31:21

Quality Excellence at UCB: Liesbeth Foesters on...

PharmaSource Podcast ·

2025/03/16

“I believe that if a quality culture is really embedded, the quality organisation starts reducing, because the more quality is embedded in the organisation, the less you need quality to help you think.” – Liesbeth FoestersLiesbeth Foesters, Vice President and Head of External and Clinical Supply Quality at UCB, leads a multinational team of over 130 quality professionals who collaborate across various functions including CMC, supply chain, external manufacturing, and more. With a background in

en

00:37:39

Digital Marketing in Pharma: Sciential's Maurice van...

PharmaSource Podcast ·

2025/03/12

Maurice van Rotterdam, Co-Founder of Netherlands-based digital marketing agency Sciential, believes many pharma suppliers and CDMOs are still missing the mark when it comes to effective digital marketing."If I look at pharma supplier or CDMO websites, they typically have a broad service portfolio and multiple target audiences that need to land on a specific webpage. You might attract a lot of leads, but customers then land on a page that is not working."In the latest episode of the

en

00:27:16

Europe Can't Compete on Price Alone - Why The Drug...

PharmaSource Podcast ·

2025/03/09

"Seven out of ten medicines dispensed in Europe are generic products. When we only look at price, we don't take into consideration all the efforts European companies make on sustainability. This is an industry we must protect," says Elisabeth Stampa, Vice President of Medicines for Europe.Elisabeth Stampa, Vice President of Medicines for Europe and Chair of the Board at Medichem, brings over two decades of pharmaceutical industry expertise. She has transformed Medichem from a pure API

en

00:50:01

How NVIDIA's AI Platforms are Reshaping the Future of...

PharmaSource Podcast ·

2025/03/05

"We can cut preclinical development from five years to 18 months. Molecules which are AI-enabled in some way seem to be doing better in Phase 1 than standard molecules." - Dr. Eva-Maria Hempe, Head of Healthcare & Life Sciences EMEA at NVIDIADr. Eva-Maria Hempe leads healthcare and life sciences for NVIDIA across Europe, combining a background in physics with a PhD in healthcare services design to drive AI innovation across the pharmaceutical industry.In the latest episode of the

en

00:39:44

Run Faster to Survive: Polpharma's Olaf Birkenmeier...

PharmaSource Podcast ·

2025/03/02

“You don’t just need to be good; you need to be better than others to drive your business,” warns Olaf Birkenmeier, Head of External Manufacturing at Polpharma Biologics, describing the evolutionary pressure facing Western biopharmaceutical manufacturers.Olaf Birkenmeier leads external manufacturing at Polpharma Biologics, bringing senior leadership experience from Sandoz and Novartis to bear on the challenges facing by pharma companies in an increasingly competitive global market.In a recent

en

00:22:09

How Lifecore Biomedical Tackles Complex Manufacturing...

PharmaSource Podcast ·

2025/02/27

“Other CDMOs couldn’t handle these products, but we figured it out through technical grit and deep expertise,” explains Jackie Klecker, Executive Vice President of Quality and Development Services at Lifecore Biomedical.In a CDMO Live Preview episode of the PharmaSource podcast, Jackie and Ryan shared insights into how Lifecore Biomedical has built its reputation as a contract manufacturer capable of handling the most challenging manufacturing projects, particularly as it celebrates its 60th

en

00:43:39

Productivity Secrets of a Serial Pharma Services...

PharmaSource Podcast ·

2025/02/23

“Most founders dominate organisations, spending 70-hour weeks trying to control everything. But it’s not about the hours you work – it’s about the impact. That shift in mindset transformed how I built multiple successful businesses in pharma services,” explains Raman Sehgal, reflecting on his journey from startup founder to strategic leader.Raman Segal is the founder of ramarketing, a PE-backed life sciences marketing agency, Lead Candidate, a specialist pharma talent firm, and is host of Molecule

en

00:32:26

CDMO Customer Experience: Lessons from Francisco...

PharmaSource Podcast ·

2025/02/18

Francisco Blanco, founder of Conducta consulting, believes the human element in CDMO-sponsor relationships has been lost in the race for efficiency. “I feel like the human component of these relationships has been lost. When I see five-star client services from CDMOs, it’s typically not because of the strength of their processes – it’s the individual.”Francisco Blanco brings over 15 years of experience from leadership roles at Thermo Fisher and IQVIA to his consultancy Conducta, where he helps life

en

00:21:59

How AustinPx's Solvent-Free Technology Eliminates...

PharmaSource Podcast ·

2025/02/14

"We estimate about 8,000 metric tonnes of solvent per year are used by the industry to support solvent-based spray drying. That's a significant impact on cost, maintenance, safety and the environment," says Elizabeth Hickman, CEO of AustinPx, highlighting a critical sustainability challenge in pharmaceutical manufacturing.Elizabeth Hickman brings extensive experience in pharmaceutical contract manufacturing to her new role as CEO of AustinPx, having worked with several CDMOs and held

en

00:17:01

How Alfasigma’s Morpho is Reshaping CDMO Services for...

PharmaSource Podcast ·

2025/02/11

“We seek long-term partnerships where our technologies can bring genuine value-add that sustains growth. It’s not about geography – it’s about matching specialties and capabilities with companies who share our vision for innovation,” says Rocco Paracchini, Director of CDMO Business Unit Morpho at Alfasigma.Rocco Paracchini brings a blend of a biology background and extensive pharmaceutical manufacturing experience to his role as Director of Morpho at Alfasigma. After transitioning from biotech to

en

00:27:55

How will US pharma manufacturing be reshaped by the...

PharmaSource Podcast ·

2025/02/06

A perfect Storm for US Drug Manufacturing as FDA Changes, Trade Wars and M&A Surge Collide"There's optimism… but the challenges aren't day to day - it can be minute to minute," warns Gil Roth, President of the Pharma and Biopharma Outsourcing Association (PBOA), describing a pharmaceutical manufacturing sector facing unprecedented change in 2025. Gil Roth brings deep expertise in pharmaceutical policy and manufacturing legislation, having launched PBOA in 2014 as an essential

en

00:36:54

From Cars to Cures: What Pharma Can Learn from...

PharmaSource Podcast ·

2025/02/05

“The automotive industry was once in a similar setup to big pharma players, but they evolved through closer supplier collaboration and continuous improvement practices,” says Fabrice Le Garrec, drawing parallels between today’s pharmaceutical manufacturing challenges and the automotive industry’s transformation. “Toyota’s model of developing suppliers as an extension of your company is something pharma isn’t doing enough of.” Fabrice Le Garrec brings extensive pharmaceutical operations experience

en

179 results

Similar Podcasts

X Minus 1 - Old Time Radio Show

Inception Point Ai

Science, Spoken

WIRED

This Week in Space (Audio)

TWiT

DarshanTalks Podcast

Darshan Kulkarni

The Best of Coast to Coast AM

iHeartPodcasts and Coast to Coast AM